Robotic TMVR system used for the first time in USA

Santiago Garcia

Capstan Medical has announced the successful completion of its first US robot-assisted transcatheter mitral valve replacement (TMVR) procedure.

The procedure was performed 9 November at The Christ Hospital in Cincinnati by a team led by Santiago Garcia, director of the hospital’s Structural Heart programme. The procedure was conducted as part of a U.S. Food and Drug Administration (FDA)-authorised early feasibility study.

“This first US procedure represents another significant step forward in the treatment of structural heart disease. I am pleased to report that the procedure was successful, and the patient was discharged home in stable condition,” said Garcia. “The robotic platform is designed to provide catheter stability and control, enabling precise positioning of the mitral valve implant. This technology has the potential to fundamentally change what is possible for patients who cannot undergo conventional heart surgery, which remains an important unmet clinical need.”

Capstan’s investigational TMVR technology combines a flexible, multi-axis catheter, robotic navigation and a novel valve implant, and is designed to treat a greater number of mitral valve patients and overcome the challenges of navigating the heart’s complex anatomy, according to the company.

The system enables physicians to perform the TMVR procedure via inputs from a handheld controller with precise control over catheter movement, valve positioning and deployment.

“This first US case builds on our initial clinical experience and brings us another step closer to expanding treatment options to patients who need them most,” said Maggie Nixon, CEO of Capstan Medical. “The Capstan technology lays the foundation for what heart valve intervention should be; simple, reproducible and low-stress. We couldn’t be more excited for this milestone that makes that future a reality.”

The milestone follows Capstan’s first-in-human robotic-assisted mitral valve replacement procedures, completed in Chile and announced in March 2025. Garcia was also present in those procedures.


LEAVE A REPLY

Please enter your comment!
Please enter your name here